Pattern of increasing HbA_1c levels in patients with diabetes mellitus before clinical detection of pancreatic cancer – a population-based nationwide case-control study

References

• Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin 2011;61:69–90.
   PubMed Web of Science ®Google Scholar
• Baxter NN, Whitson BA, Tuttle TM. Trends in the treatment and outcome of pancreatic cancer in the United States. Ann Surg Oncol 2007;14:1320–6.
   PubMed Web of Science ®Google Scholar
• Wolfgang CL, Herman JM, Laheru DA, Klein AP, Erdek MA, Fishman EK, et al. Recent progress in pancreatic cancer. CA Cancer J Clin 2013;63:318–48.
   PubMed Web of Science ®Google Scholar
• Pannala R, Basu A, Petersen GM, Chari ST. New-onset diabetes: A potential clue to the early diagnosis of pancreatic cancer. Lancet Oncol 2009;10:88–95.
   PubMed Web of Science ®Google Scholar
• Elena JW, Steplowski E, Yu K, Hartge P, Tobias GS, Brotzman MJ, et al. Diabetes and risk of pancreatic cancer: A pooled analysis from the pancreatic cancer cohort consortium. Cancer Cause Control 2013;24:13–25.
   PubMed Web of Science ®Google Scholar
• Li D, Tang H, Hassan MM, Holly EA, Bracci PM, Silverman DT. Diabetes and risk of pancreatic cancer: A pooled analysis of three large case-control studies. Cancer Cause Control 2011;22:189–97.
   PubMed Web of Science ®Google Scholar
• Eijgenraam P, Heinen MM, Verhage BA, Keulemans YC, Schouten LJ, van den Brandt PA. Diabetes type II, other medical conditions and pancreatic cancer risk: A prospective study in The Netherlands. Br J Cancer 2013; 109:2924–32.
   PubMed Web of Science ®Google Scholar
• Liao KF, Lai SW, Li CI, Chen WC. Diabetes mellitus correlates with increased risk of pancreatic cancer: A population-based cohort study in Taiwan. J Gastroenterol Hepatol 2012;27:709–13.
   PubMed Web of Science ®Google Scholar
• Wolpin BM, Bao Y, Qian ZR, Wu C, Kraft P, Ogino S, et al. Hyperglycemia, insulin resistance, impaired pancreatic beta-cell function, and risk of pancreatic cancer. J Natl Cancer Inst 2013;105:1027–35.
   PubMedGoogle Scholar
• Grote VA, Rohrmann S, Nieters A, Dossus L, Tjonneland A, Halkjaer J, et al. Diabetes mellitus, glycated haemoglobin and C-peptide levels in relation to pancreatic cancer risk: A study within the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort. Diabetologia 2011; 54:3037–46.
   PubMed Web of Science ®Google Scholar
• Sah RP, Nagpal SJ, Mukhopadhyay D, Chari ST. New insights into pancreatic cancer-induced paraneoplastic diabetes. Nature Rev Gastroenterol Hepatol 2013;10: 423–33.
   PubMed Web of Science ®Google Scholar
• Pannala R, Leibson CL, Rabe KG, Timmons LJ, Ransom J, de Andrade M, et al. Temporal association of changes in fasting blood glucose and body mass index with diagnosis of pancreatic cancer. Am J Gastroenterol 2009;104:2318–25.
   PubMed Web of Science ®Google Scholar
• Sacks DB. A1C versus glucose testing: A comparison. Diabetes Care 2011;34:518–23.
   PubMed Web of Science ®Google Scholar
• Gudbjornsdottir S, Cederholm J, Nilsson PM, Eliasson B, Steering Committee of the Swedish National Diabetes R. The National Diabetes Register in Sweden: An implementation of the St. Vincent Declaration for Quality Improvement in Diabetes Care. Diabetes Care 2003;26:1270–6.
   PubMed Web of Science ®Google Scholar
• Wettermark B, Hammar N, Fored CM, Leimanis A, Otterblad Olausson P, Bergman U, et al. The new Swedish Prescribed Drug Register – opportunities for pharmacoepidemiological research and experience from the first six months. Pharmacoepidemiol Drug Saf 2007;16:726–35.
   PubMed Web of Science ®Google Scholar
• Ludvigsson JF, Otterblad-Olausson P, Pettersson BU, Ekbom A. The Swedish personal identity number: Possibilities and pitfalls in healthcare and medical research. Eur J Epidemiol 2009;24:659–67.
   PubMed Web of Science ®Google Scholar
• Nationella Diabetesregistret. [Årsrapport 2012 års resultat]. 2012.
   Google Scholar
• Barlow L, Westergren K, Holmberg L, Talback M. The completeness of the Swedish Cancer Register: A sample survey for year 1998. Acta Oncol 2009;48:27–33.
   PubMed Web of Science ®Google Scholar
• The Swedish National Board of Health and Welfare. [The Swedish Patient Register]. [cited 2012 Aug 6]. Available from: http://www.socialstyrelsen.se/register/halsodataregister/patientregistret.
   Google Scholar
• The Swedish National Board of Health and Welfare. Swedish Causes of Death Register – Bortfall och kvalitet i dödsorsaksregistret. [cited 2012 Aug 6]. Available from: http://www.socialstyrelsen.se/register/dodsorsaksregistret/bortfallochkvalitet.
   Google Scholar
• Statistics Sweden. The Swedish Register of Education. [cited 2012 Aug 6]. Available from: http://www.scb.se/Pages/SubjectArea_3930.aspx.
   Google Scholar
• Statistics Sweden. [Register of Total Population]. [cited 2012 Aug 6]. Available from: http://www.scb.se/Pages/SubjectArea_1954.aspx.
   Google Scholar
• Wang MH, Shugart YY, Cole SR, Platz EA. A simulation study of control sampling methods for nested case-control studies of genetic and molecular biomarkers and prostate cancer progression. Cancer Epidemiol Biomarkers Prev 2009;18:706–11.
   PubMed Web of Science ®Google Scholar
• Hoelzel W, Weykamp C, Jeppsson JO, Miedema K, Barr JR, Goodall I, et al. IFCC reference system for measurement of hemoglobin A1c in human blood and the national standardization schemes in the United States, Japan, and Sweden: A method-comparison study. Clin Chem 2004;50:166–74.
   PubMed Web of Science ®Google Scholar
• Chari ST. Detecting early pancreatic cancer: Problems and prospects. Semin Oncol 2007;34:284–94.
   PubMed Web of Science ®Google Scholar
• Kaur S, Baine MJ, Jain M, Sasson AR, Batra SK. Early diagnosis of pancreatic cancer: Challenges and new developments. Biomarker Med 2012;6:597–612.
   PubMed Web of Science ®Google Scholar